AstraZeneca signs LOI with IDT Biologika to boost Europe’s Covid-19 vaccine-making capability

Cambridge-based global, science-led biopharmaceutical company AstraZeneca and German manufacturer of viral vaccines and biologics IDT Biologika have signed a Letter of Intent (LOI) to increase Europe’s Covid-19 vaccine

The post AstraZeneca signs LOI with IDT Biologika to boost Europe’s Covid-19 vaccine-making capability appeared first on Pharmaceutical Business review.

This is not a CAPTIS article. Originally, it was published here.